Odefsey
My Prescription
Payment
Select pharmacy
$2,774.55
$30.00 due at pharmacy
$2,774.55 - $30.00 = $2,744.55
$2,744.55 remaining balance
You will be given your coupon after you complete your purchase with PayPal.
AlbertsonsPowered by$2,774.55
Print or send this coupon to your phone
AlbertsonsPowered byAbout Odefsey
Drug Details
Odefsey is a single-tablet regimen used to manage HIV infection. It combines three antiretroviral medications: emtricitabine, rilpivirine, and tenofovir alafenamide. These drugs work together to reduce the amount of HIV in the body, enhancing the immune system's function and decreasing the risk of HIV-related complications such as new infections and cancer. Emtricitabine and tenofovir alafenamide are classified as nucleoside reverse transcriptase inhibitors (NRTIs), while rilpivirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). Although Odefsey is not a cure for HIV, it helps in controlling the infection and improving the quality of life. To minimize the risk of spreading HIV, it is crucial to continue taking all prescribed HIV medications, use effective barrier methods during sexual activity, and avoid sharing personal items that may come into contact with blood or bodily fluids. Always consult your healthcare provider for personalized medical advice.
Price history for Odefsey
30 Tablets, 200-25-25MG
Average retail price for Odefsey
Average SaveHealth price for Odefsey
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Odefsey dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 200-25-25MG | 30 Tablets | $2,774.55 | $92.49 |
Odefsey FAQs
Odefsey is used for the treatment of HIV-1 infection in adults and pediatric patients who are at least 12 years old and weigh at least 35 kg. It is a combination antiretroviral medication that helps to control the virus, thereby improving the immune system function and reducing the risk of developing HIV-related complications.
Descovy and Odefsey are both medications used in the treatment of HIV, but they have different compositions and uses. Descovy is a combination of two drugs: emtricitabine and tenofovir alafenamide. It is primarily used as part of a combination therapy for the treatment of HIV-1 infection and for pre-exposure prophylaxis (PrEP) to reduce the risk of HIV-1 infection in certain individuals.Odefsey, on the other hand, is a combination of three drugs: emtricitabine, tenofovir alafenamide, and rilpivirine. It is used as a complete regimen for the treatment of HIV-1 infection in patients who are either treatment-nave or virologically suppressed on a stable antiretroviral regimen.In summary, the main difference lies in their composition and specific use cases in HIV treatment.
Odefsey does not suppress the immune system. It is an antiretroviral medication used to treat HIV-1 infection and works by reducing the amount of virus in the body, helping to maintain a healthy immune system.
Dovato and Odefsey are both antiretroviral medications used in the treatment of HIV-1 infection, but they differ in their composition and specific use cases.Dovato is a combination of two drugs: dolutegravir and lamivudine. It is typically used as a complete regimen for the treatment of HIV-1 in adults who have not previously been treated with antiretroviral therapy or to replace a current antiretroviral regimen in certain patients.Odefsey, on the other hand, is a combination of three drugs: emtricitabine, rilpivirine, and tenofovir alafenamide. It is used as a complete regimen for the treatment of HIV-1 in adults and pediatric patients who are virologically suppressed on a stable antiretroviral regimen.The choice between these medications depends on individual patient factors, including treatment history, potential drug interactions, and specific health considerations.
Odefsey should not be taken with certain medications due to potential interactions. These include, but are not limited to, anticonvulsants like carbamazepine, oxcarbazepine, phenobarbital, and phenytoin; antimycobacterials such as rifampin and rifapentine; proton pump inhibitors like omeprazole; and certain herbal supplements like St. John's Wort. It is important to consult with a healthcare provider for a comprehensive list and guidance specific to individual health needs.